Press release Read more about ABIONYX Pharma has completed a successful pre-IND meeting with the FDAfor CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis
Press release Read more about GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
Press release Read more about Worldline - 2024 General meeting - Approval of all resolutions - Press Release